News from Wednesday, October 2, 2024
Articles
VUMC Awarded PCORI Funding to Improve Antibiotic Prescribing for Childhood Respiratory Infections
(10/2, Leigh MacMillan, VUMC News) reports “Vanderbilt University Medical Center has been approved for a $1 million funding award from the Patient-Centered Outcomes Research Institute (PCORI) to help improve antibiotic prescribing for children with acute respiratory tract infections in outpatient settings.” Full
WellSpan Awarded Nearly $1M in PCORI Funding
(10/2, The WellSpan Spotlight) reports “WellSpan Health has been approved for a nearly $1 million funding award by the Patient-Centered Outcomes Research Institute (PCORI) to help improve antibiotic prescribing for children with acute respiratory tract infections in all of its urgent care and pediatric practices as well as select primary care practices across the central Pennsylvania...‘With this funding award we can quickly put to practice evidence-based research to improve the lives of our youngest patients here in central Pennsylvania,’ said Dr. Michael Seim, senior vice president and chief quality officer for WellSpan Health.” Full
Can Telehealth Help Patients Stick with Buprenorphine for Opioid Addiction?
(10/1, Nadine A Yehya, UC Davis Health) reports “A clinical trial led by UC Davis Health physicians aims to improve the long-term use of buprenorphine, a critical medication for treating patients with opioid use disorder (OUD). The new study focuses on patients prescribed buprenorphine in emergency departments, where there is a need for effective follow-up care...The $6.4 million study is funded by the Patient-Centered Outcomes Research Institute.” Full
CMS Should 'Clarify' Part B Inflation Rebates Don't Apply In Medicare Advantage, Pharma Says
(10/1, Cathy Kelly, Pink Sheet) reports “...Manufacturers 'strongly object' to the possibility floated by the Centers for Medicare and Medicaid Services that it could extend price inflation rebates to Part B drugs furnished to enrollees in Medicare Advantage plans in addition to those covered by fee-for-service Medicare...PhRMA also urged CMS to require 340B claims modifiers for Part B drugs subject to price inflation rebates and establish a Part D claims repository to ensure drugs subject to 340B discounts are not included in the inflation rebates calculation.” Subscription Required
Press Releases
PCORI Awards $37 Million To Accelerate Implementation of Evidence-Based Health Research
(10/2, PCORI Press Release) “...‘PCORI's Health Systems Implementation Initiative innovatively bridges the gap between research and practice,’ said PCORI Executive Director Nakela L. Cook, M.D., MPH. ‘By funding projects like these, we are proactively supporting the uptake of evidence from PCORI-funded patient-centered comparative clinical effectiveness research in clinical settings. This initiative enables clinicians and health systems to not only access but also effectively scale implementation of patient-centered evidence, to improve care delivery and patient outcomes.’” Full
2024 PCORI Annual Meeting Will Showcase How PCORnet® Is Powering Maternal Health Insights
(10/2, PCORnet Press Release) “During this session, Jennifer Tang, MD, MSCR and Sonja Williams, MPH, PMP will discuss insights from a recent maternal morbidity and mortality public query report of the PCORnet infrastructure, including its representation of more than 1.5 million demographically diverse people who experienced a delivery or pregnancy disruption event.” Full
Journals
Making Pragmatic Clinical Trials More Pragmatic
Richard Platt, MD, MSc; Hayden B. Bosworth, PhD; Gregory E. Simon, MD
October 2, 2024, JAMA